HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas M Kündig Selected Research

Adenosine Deaminase

1/2022Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas M Kündig Research Topics

Disease

38Hypersensitivity (Allergy)
05/2024 - 03/2002
14Neoplasms (Cancer)
01/2022 - 06/2005
10Anaphylaxis (Anaphylactic Shock)
01/2023 - 12/2005
9Inflammation (Inflammations)
01/2024 - 06/2007
7Infections
01/2022 - 03/2002
5Peanut Hypersensitivity (Peanut Allergy)
01/2024 - 01/2020
4Asthma (Bronchial Asthma)
01/2024 - 12/2006
3Allergic Rhinitis
02/2023 - 08/2014
3Pruritus (Itching)
10/2021 - 12/2011
3Insect Bites and Stings (Insect Bite)
01/2020 - 10/2018
3Eczema
01/2015 - 11/2009
2Food Hypersensitivity (Food Allergy)
01/2024 - 01/2014
2Rhinitis
02/2023 - 12/2009
2Immediate Hypersensitivity
01/2023 - 10/2007
2Bites and Stings (Sting)
01/2022 - 01/2013
2Lymphoma (Lymphomas)
01/2022 - 07/2021
2Psoriasis (Pustulosis Palmaris et Plantaris)
10/2021 - 06/2007
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 01/2013
2Rheumatoid Arthritis
01/2018 - 06/2007
2Contact Dermatitis (Eczema, Contact)
06/2010 - 03/2002
1Hyperplasia
01/2024
1Hypertrophy
01/2024
1Venom Hypersensitivity
01/2023
1Leukemia
01/2022
1Bacterial Infections (Bacterial Infection)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Eosinophilia
10/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
07/2021
1Chronic Disease (Chronic Diseases)
10/2018
1Colitis
01/2018
1Colonic Neoplasms (Colon Cancer)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Cowpox
10/2014
1Atherosclerosis
03/2013

Drug/Important Bio-Agent (IBA)

28AllergensIBA
01/2024 - 12/2005
16VaccinesIBA
01/2023 - 07/2004
15Immunoglobulin E (IgE)IBA
01/2024 - 11/2008
5AntibodiesIBA
01/2023 - 08/2010
5CytokinesIBA
01/2023 - 06/2007
5AntigensIBA
01/2022 - 10/2009
4Interleukin-5 (Interleukin 5)IBA
01/2024 - 10/2018
4Immunoglobulin G (IgG)IBA
01/2022 - 12/2005
3Bee Venoms (Bee Venom)IBA
01/2023 - 01/2013
3hypoxanthine arabinoside (ara-H)IBA
01/2023 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2009
2Protamines (Protamine Sulfate)FDA Link
01/2022 - 10/2007
2RNA (Ribonucleic Acid)IBA
01/2022 - 10/2021
2Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2007
2Messenger RNA (mRNA)IBA
07/2021 - 01/2021
2Neutralizing AntibodiesIBA
01/2020 - 03/2013
2SaltsIBA
01/2020 - 03/2018
2InterleukinsIBA
01/2020 - 03/2013
2AluminumIBA
01/2020 - 03/2018
2Clemastine (Clemastine Fumarate)FDA LinkGeneric
02/2013 - 12/2011
2Histamine Antagonists (Antihistamines)IBA
02/2013 - 12/2011
2Arthropod VenomsIBA
01/2013 - 12/2006
2CPG-oligonucleotideIBA
11/2012 - 06/2005
2OligonucleotidesIBA
11/2012 - 03/2002
2Peptides (Polypeptides)IBA
06/2007 - 03/2002
1Interleukin-13IBA
01/2024
1Interleukin-4 (Interleukin 4)IBA
01/2024
1Biomarkers (Surrogate Marker)IBA
07/2023
1EpitopesIBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1Pentostatin (Nipent)FDA LinkGeneric
01/2022
1Adenosine DeaminaseIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Toll-Like Receptor 3IBA
01/2022
1Interferon Type IIBA
01/2022
1Interleukin-12 (IL 12)IBA
10/2021
1Imiquimod (Aldara)FDA LinkGeneric
10/2021
1Interleukin-23 Subunit p19IBA
10/2021
1Therapeutic UsesIBA
07/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2021
1BNT162 VaccineIBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1Histocompatibility Antigens Class IIBA
01/2020
1monophosphoryl lipid AIBA
01/2020
1AutoantibodiesIBA
10/2018
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
03/2018
1aluminum sulfate (alum)IBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2018
1Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
01/2018
1InflammasomesIBA
01/2018
1Photosensitizing Agents (Photosensitizers)IBA
07/2015
1Interleukin-2 (IL2)IBA
07/2015
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2013
1Apolipoproteins E (ApoE)IBA
03/2013

Therapy/Procedure

23Immunotherapy
05/2024 - 12/2006
7Therapeutics
01/2022 - 06/2007
3Injections
05/2024 - 11/2009
2Drug Therapy (Chemotherapy)
01/2020 - 02/2013
1Aftercare (After-Treatment)
02/2023
1Microspheres (Microsphere)
10/2021
1Duration of Therapy
02/2016